Effect of transdermally administered fentanyl on the minimum alveolar concentration of isoflurane in cats

OBJECTIVE: To determine the effect of two doses of fentanyl, administered transdermally, on the minimum alveolar concentration (MAC) of isoflurane in cats. STUDY DESIGN: Prospective, randomized study. ANIMALS: Five healthy, spayed, female cats. METHODS: Each cat was studied thrice with at least 2 weeks between each study. In study 1, the baseline isoflurane MAC was determined in triplicate for each cat. In studies 2 and 3, isoflurane MAC was determined 24 hours after placement of either a 25 or 50 microg hour(-1) fentanyl patch. In each MAC study, cats were instrumented to allow collection of arterial blood and measurement of arterial blood pressure. Twenty-four hours prior to studies 2 and 3, a catheter was placed and secured in the jugular vein and either a 25 or 50 microg hour(-1) fentanyl patch was placed in random order on the left thorax. Blood samples for plasma fentanyl determination were collected prior to patch placement and at regular intervals up to 144 hours. After determination of MAC in studies 2 and 3, naloxone was administered as a bolus dose (0.1 mg kg(-1)) followed by an infusion (1 mg kg(-1) hour(-1)) and MAC redetermined. RESULTS: The baseline isoflurane MAC was 1.51 +/- 0.21% (mean +/- SD). Fentanyl (25 and 50 micro g hour(-1)) administered transdermally significantly reduced MAC to 1.25 +/- 0.26 and 1.22 +/- 0.16%, respectively. These MAC reductions were not significantly different from each other. Isoflurane MAC determined during administration of fentanyl 25 micro g hour(-1) and naloxone (1.44 +/- 0.16%) and fentanyl 50 micro g hour(-1) and naloxone (1.51 +/- 0.19%) was not significantly different from baseline MAC (1.51 +/- 0.21%). CONCLUSIONS AND CLINICAL RELEVANCE: Fentanyl patches are placed to provide long-lasting analgesia. In order to be effective postoperatively, fentanyl patches must be placed prior to surgery. Plasma fentanyl concentrations achieved intraoperatively decrease the need for potent inhalant anesthetics in cats.     

The effect of vitamins C and E in (n-3) highly unsaturated fatty acids-enriched Artemia nauplii on growth, survival, and stress resistance of fresh water walleye Stizostedion vitreum larvae

This study aimed to evaluate the effect of enriching Artemia nauplii with vitamin C (ascorbyl-6 palmitate) or vitamin E (α-tocopherol acetate), 20% w/w, together with a mixture of concentrated eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3) on the growth, survival, and stress resistance of fresh water walleye Stizostedion vitreum larvae. Either cod liver oil (CLO) or EPA/DHA ethyl esters concentrate was used as lipid sources in the Artemia enrichment. Walleye larvae were fed ad libitum for 40 days. At day 40, submersion in salt water (25 g L⁻¹) was performed to evaluate larvae resistance to stress. EPA and DHA levels in walleye juveniles fed EPA/DHA-enriched Artemia increased significantly, by an average of 650% compared with fish fed non-enriched Artemia . A significant increase was found for vitamins C (71.8 ± 1.0 and 42.7 ± 1.2 μg g⁻¹ wet weight (WW)) and E (17.0 ± 3.7 and 6.5 ± 0.9 μg g⁻¹WW) concentrations in fish fed enriched and unenriched Artemia , respectively. Growth was comparable throughout treatments, whereas survival was significantly higher in fish fed CLO-enriched Artemia nauplii compared with fish fed Artemia nauplii enriched with EPA/DHA concentrate. The addition of vitamin C increased fish survival by 1.4-fold compared with fish fed Artemia enriched with only EPA/DHA concentrate. The survival of the latter was similar to control fish ( Artemia without enrichment). The supplementation of vitamin E did not affect fish survival significantly. Stress tests revealed that the resistance of walleye larvae to salinity changes increased when Artemia enrichment was supplemented with vitamin C. However, walleye larvae fed CLO-enriched Artemia had the best performances in the stress test.